A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2

Wanbo Tai, Xiujuan Zhang, Aleksandra Drelich, Juan Shi, Jason C. Hsu, Larry Luchsinger, Christopher D. Hillyer, Chien Te K. Tseng, Shibo Jiang, Lanying Du

Research output: Contribution to journalLetter

Original languageEnglish (US)
JournalCell Research
DOIs
StateAccepted/In press - 2020

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Cite this

Tai, W., Zhang, X., Drelich, A., Shi, J., Hsu, J. C., Luchsinger, L., Hillyer, C. D., Tseng, C. T. K., Jiang, S., & Du, L. (Accepted/In press). A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2. Cell Research. https://doi.org/10.1038/s41422-020-0387-5